lowest (10%) within patients presenting co-morbidities and lower than the overall mortality. This finding reopens the debate about the low acute mortality of patients with COPD presenting with CAP. In fact COPD was a protective factor for treatment failure in one study. 15 Although the rate of acute treatment with steroids in patients with COPD is not reported in the study of Ewig et al, it is highly likely that a high percentage of them could have received such treatment, which could have attenuated the lung and systemic inflammatory response leading to a lower mortality. 16 On the other hand, recent information suggests that despite the fact that previous inhaled steroid treatment may increase the risk of hospitalised CAP 17 it may be associated with lower CAP severity and consequently lower mortality. 18 The number of patients requiring mechanical ventilation was lower compared with other studies, particularly in advanced ages. As recognised by the authors, this could be due to treatment limitations such as ''do not resuscitate'' orders, or avoiding intensive care unit admission in older ages and severely disabled strata. This issue could not be analysed in detail by the authors. These are factors that might have influenced the high mortality of German hospitalised patients with CAP in this large study. This is a common error in most retrospective studies of CAP. For future studies it is highly recommended to record these two variables in order to interpret reliable data on mortality more precisely.
Finally, this study confirms in a large population the good performance of CRB-65 to predict mortality in CAP in a threeclass pattern, a score much easier and less tedious to calculate than the PSI 19 and which further simplifies similar scores such as CURB and CURB-65. The data presented by Ewig et al 4 are currently the most solid and informative data available about hospitalisation rates in patients with CAP. The information reported in this study reminds us that this is an acute illness which occurs particularly in the elderly, a population which is going to increase in the next decades. CAP in this population currently represents an enormous economic and healthcare burden, and this burden will increase substantially in future years. Programmes of prevention are the only effective way to decrease the magnitude of this problem. We are delighted to be able to let you all know that Thorax has continued to have a very successful past year. As usual, we nervously awaited the impact factor announcements in June 2009 and we were all delighted with the news that surpassed our expectations that our impact factor for 2008 had risen to the highest ever for Thorax at 7.069. This increase in the impact factor is due to the high quality papers and reviews that you have all submitted to the journal for publication. We have thus maintained our position as the second highest ranked respiratory journal in terms of impact factor, behind the American Journal of Respiratory and Critical Care Medicine. During the last year, we have published a number of original papers and guidelines that are likely to be highly cited, and we can see the Thorax impact factor rising even further in June 2010. Please continue to send us your very best papers over the coming year.
There has been a sharp rise in the numbers of submissions to the journal over the past few months that may reflect the rise in impact factor and we have nearly 1600 submissions over the past year, which is the highest number of submissions ever received by the journal. As usual the submissions come from all over the world and we are continuing to see a rise in submissions from outside Europe. BMJ Publishing have also introduced a ''Portal'' whereby authors can submit to more than one journal. In the event of rejection by the first-choice journal, papers and any associated peer reviews in the event of rejection are passed to the second choice, and thus down the portal. Our publication lag time between acceptance and publication in the print version is now short and under 3 months, though papers are also posted in the ''Online First'' section of the Thorax web site as soon as they are accepted for publication. We are publishing in this issue the names of the peer reviewers who have helped us assess papers over the past years. We are especially grateful to all our reviewers for their expertise and time they have given to the journal.
Since the start of our editorship, we have always tried to ensure that there is something in Thorax each month of interest to all readers, and thus educational features are important for the success of the journal. Our ''Pulmonary Puzzle'' feature with a question and answer format has proved very popular and we are suggesting that a number of submitted case reports are converted into this format. We are encouraging authors of case reports to submit them in the ''Puzzle'' format. However, we have discussed the value of case reports at our editorial board meetings and decided that we should continue to publish selected case reports, as they do play an important role in describing novel case descriptions or a new adverse effect of a particular treatment. The ''Images in Thorax'' series has been running for some time and is very popular with authors; they are also available on the Thorax web site in a collection. We are very grateful to Mark Fitzgerald (Associate Editor) who has edited the case reports, Puzzles and Images so well and made them such a valuable educational resource for our readers. Our Lung Alerts have proved very popular, and are organised and edited by Angshu Bhowmik and Jenni Quint. We have decided to start a Thorax Podcast feature, and the first one can be found on the web site this month.
We would like to thank our excellent and skilful team of Associate Editors, most of whom have been with us now for 7 years and have contributed to the high quality of the journal by selecting only the very best papers for publication. This 
